Fiche société
Icure Pharmaceutical Inc.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications15liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| DonepezilStudy of the Safety, tolerability and pharmacokinetics with multiple doses of donepezil patch in healthy male subjects | Alzheimer | Phase 1 | À vérifier | South Korea | À vérifier |
| DonepezilStudy of the Safety, tolerability and pharmacokinetics with multiple doses of donepezil patch in healthy male subjects | Alzheimer | Phase 1 | À vérifier | South Korea | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Donepezil | Alzheimer | Phase 1 | NCT02178124 | A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects. | COMPLETED |
Publications
15| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Donepezil | Neuroprotective effects of aqueous extract of Pterocarpus mildbraedii Harms. on some biochemical markers in Alzheimer's disease using an AlCl-induced rat model: Integrated ADMET, network pharmacology, molecular docking, and in vivo experimental validation. | Journal of ethnopharmacology | ||
| Donepezil | Mechanisms of electroacupuncture for the treatment of Alzheimer's disease by activating Wnt/β-catenin pathway to improve blood-brain barrier function. | IBRO neuroscience reports | ||
| Donepezil | Chrono-Nanomedicine at the Barrier: Circadian Rhythms Influence the Delivery of Donepezil Across the BCSFB. | International journal of molecular sciences | ||
| Donepezil | CellSwarm-AD: A Multi-Scale Agent-Based Framework for Virtual Alzheimer's Disease Trials. | International journal of molecular sciences | ||
| Donepezil | Valorization of 2-aminoethoxydiphenyl borate as a neurotherapeutic agent: modulation of calcineurin, TRPC1 and MARK2/GSK-3β signaling in scopolamine-triggered tauopathy. | Inflammopharmacology | ||
| Donepezil | Daturaolone from L. Inhibits acetylcholinesterase and monoamine oxidase B. | Natural product research | ||
| Donepezil | Design, synthesis, biological evaluation, and in silico analysis of novel coumarin carboxamides as acetylcholinesterase and butyrylcholinesterase inhibitors and anticancer agents. | Journal of computer-aided molecular design | ||
| Donepezil | Donepezil-induced manic episodes in two patients with different types of dementia. | Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi | ||
| Donepezil | Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells. | Bioorganic chemistry | ||
| Donepezil | Hospitalization for Malignant Arrhythmias Following Initiation of Donepezil: A Retrospective Cohort Study. | Pharmacoepidemiology and drug safety | ||
| Donepezil | Predicting drug release from polymeric long-acting injectables using a machine learning approach to decode formulation-performance relationships. | Drug delivery and translational research | ||
| Donepezil | RGD-functionalized cannabidiol lipid nanoparticles improve brain delivery and alleviate cognitive and metabolic dysfunction via gut-brain axis modulation in an Alzheimer's disease model. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | ||
| Donepezil | Synthesis, characterization, and biocompatibility evaluation of donepezil-loaded magnetite-PLGA nanoparticles in neuroblastoma cells. | Scientific reports | ||
| Donepezil | EphB1-Mediated Transient Blood-Brain Barrier Opening Facilitates a Ferritin-Based Nanotherapeutic for Alzheimer's Disease. | Advanced science (Weinheim, Baden-Wurttemberg, Germany) | ||
| Donepezil | Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease. | Alzheimer disease and associated disorders |